Evidence map›Paper›PMID 42106879›Full record

ArticleResearch integrity and peer review2026

A call for clarity: a unified checklist for reporting use of large language models in writing scientific manuscripts.

Neil Mehta, Ryan Marshall Felder, Eric Kodish, Peter B Imrey, Richard M Frankel

Abstract readLetter
In one paragraph

Article in Research integrity and peer review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Neil MehtaCleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. mehtan@ccf.org.ORCID http://orcid.org/0000-0001-8342-4252
Ryan Marshall FelderCleveland Clinic Center for Bioethics, Cleveland, Ohio, USA.ORCID http://orcid.org/0000-0003-1306-4946
Eric KodishCleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID http://orcid.org/0009-0000-1609-3609
Peter B ImreyDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID http://orcid.org/0000-0002-0533-4603
Richard M FrankelIndiana University School of Medicine, Indianapolis, Indiana, USA.ORCID http://orcid.org/0000-0003-4132-4506

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid integration of generative artificial intelligence (Gen AI) into academic writing has outpaced the establishment of consistent norms for responsible and transparent disclosure. Leading organizations including the International Committee of Medical Journal Editors (ICMJE), the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME), and the European Commission, Directorate-General for Research and Innovation have issued guidance affirming that AI tools cannot be listed as authors and must be transparently disclosed. However, what remains missing is both a cross-journal consensus and guidance for authors on what constitutes acceptable versus unacceptable use of Gen AI. Furthermore, as authors may employ Gen AI at multiple, distinct stages of manuscript preparation, they currently have no standardized or granular method to report this varied use in sufficient detail. This ambiguity creates a critical gap between high-level disclosure principles and practical implementation, threatening not necessarily the integrity of the underlying research itself, but the reader's and editor's ability to objectively assess the reliability and provenance of reported findings.This paper responds to that gap by proposing a structured, domain-based framework for reporting Gen AI use in scholarly manuscripts. Drawing on a synthesis of evolving editorial statements and guidelines, we outline three domains in which Gen AI is commonly employed: conceptual contributions, linguistic assistance, and research assistance. For each domain, we distinguish uses that are generally acceptable from those that raise ethical or integrity concerns, providing examples to guide authors, reviewers, and journal editors and editorial staff.To operationalize this framework, we introduce a prototype of an online Gen AI use disclosure form that guides authors through documenting their use of Gen AI across the three domains. The tool automatically generates a standardized disclosure statement and assigns a unique, citable reference number. This reference number links to a persistent, publicly accessible summary of the declared Gen AI use, creating a transparent and auditable record. This system is proposed as a 'living' platform, designed to evolve through consensus among journal editors and editorial staff, authors, and research integrity organizations, functioning similarly to other reporting guidelines hosted by the EQUATOR Network.This system moves beyond ad hoc, narrative statements to establish a proactive and standardized disclosure process around the use of Gen AI in scholarly publishing. By embedding transparency, human accountability, and traceability directly into the publication workflow, our approach complements existing frameworks for authorship and conflict of interest. Like conflict-of-interest disclosures, AI use statements surface information that allows readers to contextualize potential risks and judge credibility for themselves. Ultimately, this work advances a practical model to strengthen trust between authors, journal editors and editorial staff, and readers, aligning the promise of generative AI with the enduring principles of research integrity.

Indexed as

Gen AI DisclosureGenerative Artificial IntelligencePublication ethicsResearch transparencyStandardize Acceptable AI Use

Identifiers

PMID42106879
PMCPMC13157658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.